by admin | Mar 10, 2010 | My blogs
From theheart.org, by Michael O’Riordan Baltimore, MD – Adding the investigational thyroid hormone analog eprotirome (Karo Bio) to statin therapy in patients with dyslipidemia results in substantially further reductions in LDL cholesterol and other lipid and...
Recent Comments